Mankind Pharma
Mankind Pharma Limited, headquartered in New Delhi, India, is a prominent pharmaceutical company established in 1986 that focuses on the formulation, development, commercialization, and delivery of a wide array of pharmaceutical products. The company offers a diverse portfolio that includes antibiotics, antifungals, non-steroidal anti-inflammatory drugs (NSAIDs), gastrointestinal treatments, cardiovascular medications, and contraceptives, alongside over-the-counter medicines and nutritional supplements. Mankind Pharma also provides active pharmaceutical ingredients across various therapeutic areas such as cardiology, neurology, and gynecology. With a workforce exceeding 14,000, the company has built a strong presence in both the pharmaceutical and consumer healthcare sectors, catering primarily to the Indian market while also extending its reach to regions in Asia, Africa, Latin America, and the Gulf countries. Mankind Pharma is recognized for its well-established brands, including Manforce, Prega News, and Gas-O-Fast, and is committed to delivering affordable healthcare solutions to meet urgent medical needs.
Innov8 Coworking
Venture Round in 2025
Innov8 Coworking is a Y-Combinator backed startup based in India that offers premium workspaces, including managed private offices and coworking spaces. As the first of its kind in India, Innov8 Coworking creates a productive environment that fosters community engagement among diverse individuals such as founders, investors, freelancers, and creators. The company currently operates multiple centers across major cities in India, including Delhi, Noida, Gurgaon, Mumbai, Bangalore, and Chandigarh. Innov8 Coworking provides essential amenities such as high-speed internet, meeting and conference rooms, and complimentary beverages, all aimed at facilitating collaboration and idea sharing among startup businesses.
Bharat Serums and Vaccines
Acquisition in 2024
Bharat Serums and Vaccines Limited is a biopharmaceutical company based in Thane, India, established in 1971. The company specializes in researching, developing, manufacturing, and marketing a wide range of injectable biological and pharmaceutical products. Its diverse portfolio includes plasma derivatives, monoclonal antibodies, fertility hormones, antifungals, anesthetics, cardiovascular drugs, and equine immunoglobulins. Bharat Serums and Vaccines also focuses on advanced research and development in drug delivery systems, biotechnology therapeutics, and therapeutic proteins. It serves various medical fields such as gynecology, critical care, emergency medicine, neurology, nephrology, hematology, and urology. The company distributes its products primarily within India and extends its reach to international markets, including the Asia Pacific, Latin America, and Africa. Bharat Serums and Vaccines operates manufacturing facilities in India and Germany, along with research and development facilities in India, Germany, and the United States.
Actimed Therapeutics
Series A in 2023
Actimed Therapeutics is a clinical-stage biopharmaceutical company dedicated to innovating treatments for muscle wasting disorders, particularly cancer cachexia, a severe syndrome associated with various chronic illnesses. Founded in 2017 by Stefan Anker and Andrew Coats in Ascot, Windsor and Maidenhead, the company develops anabolic and catabolic transforming agents aimed at addressing this often fatal condition. By focusing on the management of cancer-related cachexia, Actimed Therapeutics seeks to improve care for a vulnerable patient population that has been historically underserved in this area.
Actimed Therapeutics
Series A in 2023
Actimed Therapeutics is a clinical-stage biopharmaceutical company dedicated to innovating treatments for muscle wasting disorders, particularly cancer cachexia, a severe syndrome associated with various chronic illnesses. Founded in 2017 by Stefan Anker and Andrew Coats in Ascot, Windsor and Maidenhead, the company develops anabolic and catabolic transforming agents aimed at addressing this often fatal condition. By focusing on the management of cancer-related cachexia, Actimed Therapeutics seeks to improve care for a vulnerable patient population that has been historically underserved in this area.
Actimed Therapeutics
Seed Round in 2023
Actimed Therapeutics is a clinical-stage biopharmaceutical company dedicated to innovating treatments for muscle wasting disorders, particularly cancer cachexia, a severe syndrome associated with various chronic illnesses. Founded in 2017 by Stefan Anker and Andrew Coats in Ascot, Windsor and Maidenhead, the company develops anabolic and catabolic transforming agents aimed at addressing this often fatal condition. By focusing on the management of cancer-related cachexia, Actimed Therapeutics seeks to improve care for a vulnerable patient population that has been historically underserved in this area.
Upakarma Ayurveda
Acquisition in 2022
Upakarma Ayurveda is a prominent Ayurveda brand in India, recognized for its rapid growth in the health and wellness sector. The company specializes in delivering high-quality pure Ayurvedic products that encompass health, beauty, and immunity solutions. Its product range includes shilajit, kesar, various juices, and immunity boosters, along with skin and health care items available in capsules and drops. Upakarma Ayurveda aims to promote a balanced and healthy lifestyle for its customers through its diverse offerings.
BatX Energies
Seed Round in 2022
BatX Energies operates a battery recycling platform that promotes a circular economy for lithium-ion batteries through the development and deployment of proprietary recycling technologies. The company offers a comprehensive range of services, including the collection and transportation of spent batteries, the extraction of essential metals, and the production of battery-grade materials. By facilitating these processes, BatX Energies aims to help customers minimize their environmental impact and contribute to a sustainable energy future.
Bellatrix Aerospace
Series A in 2022
Bellatrix Aerospace is an Indian space research and development company focused on advanced technologies for in-space mobility and satellite propulsion. The company specializes in eco-friendly orbital launch vehicles and systems designed for the navigation of heavy, micro, and nanosatellites. By developing innovative propulsion technologies, Bellatrix Aerospace aims to enhance in-orbit satellite navigation and provide essential tools for deep space exploration. Its commitment to sustainable practices positions the company as a key player in the aerospace industry, facilitating access to space navigation capabilities for various stakeholders.
Leverage Edu
Series B in 2022
Leverage Edu is an AI-enabled marketplace focused on assisting students with higher education and career development. As one of India's leading ed-tech companies, it aims to democratize mentorship and facilitate access to career growth opportunities. The platform offers an educational advisory service that matches students with programs and experts based on their interests. Users can browse and book admission tests for various colleges and apply to educational programs, ensuring they receive guidance from mentors worldwide. By leveraging technology, Leverage Edu seeks to break down traditional barriers in education and empower the next generation of students to navigate their academic and professional journeys effectively.
Panacea Biotec Pharma - Formulations business
Acquisition in 2022
Panacea Biotec Pharma - Formulations business offers pharma formulations.
Dogsee Chew
Series A in 2022
Dogsee Chew is formed for the love of dogs. Bhupendra wanted to bring organic foods for dogs - a healthy treat with high protein and less carbs, and he ended up with Dogsee Chew. It is a highly nutritious high quality snacking option for your dogs.
Miko is a consumer electronics company developing an artificial intelligence-based companion robot to educate and entertain children. Its platform specializes in offering a personalized learning experience and educational journey for every child where the companion robot adapts to its user's communication styles and features a parental dashboard to control the content of interactions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.